Position in PROCF
as of Dec 31, 2024
· filed Feb 14, 2025
Position Value
$0
+$0 QoQ
Shares Held
49
+16.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PROCF Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,643,241 | $261,803,294 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
9,910,822 | $243,905,327 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,616 | $119,536,366 | |
| 4 | VTRS |
Viatris Inc
|
6,092,296 | $96,745,659 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
835,494 | $92,689,703 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
2,660,810 | $92,250,281 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
545,937 | $92,012,220 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,140,065 | $72,505,400 |
All Filings in PROCF
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2024-12-31 PROC | — | 49 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 PROC | — | 42 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 PROC | — | 31,028 | Shares | Sole | 2024-02-09 | |
| 2023-06-30 PROC | — | 1 | Shares | Sole | 2023-08-11 | |
| 2022-12-31 PROC | — | 852 | Shares | Sole | 2023-02-08 | |
| 2022-06-30 PROC | — | 50 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 PROC | — | 1,085 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 PROC | — | 1,012 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 PROC | — | 42 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||